These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 27302723)

  • 1. A comparative study with depressed patients on the acceptability of placebo use.
    Feffer K; Lichtenberg P; Becker G; Bloch Y; Netzer R; Nitzan U
    Gen Hosp Psychiatry; 2016; 41():53-6. PubMed ID: 27302723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consenting not to be informed: a survey on the acceptability of placebo use in the treatment of depression.
    Nitzan U; Feffer K; Bloch Y; Lichtenberg P; Lev-Ran S; Becker G; Wolfman S; Fennig S
    J Nerv Ment Dis; 2013 Apr; 201(4):345-7. PubMed ID: 23538981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes toward placebo-controlled clinical trials among depressed patients in Japan.
    Sugawara N; Ishioka M; Tsuchimine S; Tsuruga K; Sato Y; Tarakita N; Furukori H; Kudo S; Tomita T; Nakagami T; Yasui-Furukori N
    J Affect Disord; 2018 Jan; 225():313-316. PubMed ID: 28843082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo Use in Pain Management: A Mechanism-Based Educational Intervention Enhances Placebo Treatment Acceptability.
    Kisaalita NR; Hurley RW; Staud R; Robinson ME
    J Pain; 2016 Feb; 17(2):257-69. PubMed ID: 26604097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronicity of depressive episode in relation to antidepressant-placebo response.
    Khan A; Dager SR; Cohen S; Avery DH; Scherzo B; Dunner DL
    Neuropsychopharmacology; 1991 Feb; 4(2):125-30. PubMed ID: 2025378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo treatments, informed consent and 'the grip of a false picture'.
    Glackin SN
    J Med Ethics; 2015 Aug; 41(8):669-72. PubMed ID: 25323316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo as a treatment for depression.
    Brown WA
    Neuropsychopharmacology; 1994 Jul; 10(4):265-9; discussion 271-88. PubMed ID: 7945737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes that determine willingness to seek psychiatric help for depression: a representative population survey applying the Theory of Planned Behaviour.
    Schomerus G; Matschinger H; Angermeyer MC
    Psychol Med; 2009 Nov; 39(11):1855-65. PubMed ID: 19379538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed consent and participant perceptions of influenza vaccine trials in South Africa.
    Moodley K; Pather M; Myer L
    J Med Ethics; 2005 Dec; 31(12):727-32. PubMed ID: 16319239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "I assumed that one was a placebo": exploring the consent process in a sham controlled acupressure trial.
    Hughes JG; Russell W; Breckons M; Richardson J; Lloyd-Williams M; Molassiotis A
    Complement Ther Med; 2014 Oct; 22(5):903-8. PubMed ID: 25440382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The patient's perspective of placebo use in daily practice: a qualitative study.
    Tandjung R; Tang H; Fässler M; Huber CA; Rosemann T; Fent R; Badertscher N
    Swiss Med Wkly; 2014 Feb; 144():w13899. PubMed ID: 24526325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroconvulsive therapy, the placebo effect and informed consent.
    Blease CR
    J Med Ethics; 2013 Mar; 39(3):166-70. PubMed ID: 23038801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES; Howard C; Khan DA; Carmody TJ
    Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the 'placebo effect' for CAM research.
    Relton C
    Complement Ther Med; 2013 Apr; 21(2):121-4. PubMed ID: 23497816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical aspects of clinical placebo use: what do laypeople think?
    Köteles F; Ferentzi E
    Eval Health Prof; 2012 Dec; 35(4):462-76. PubMed ID: 22831876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain.
    Bergmann JF; Chassany O; Gandiol J; Deblois P; Kanis JA; Segrestaa JM; Caulin C; Dahan R
    Clin Trials Metaanal; 1994 Apr; 29(1):41-7. PubMed ID: 10150184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.